GB0130763D0 - Treatment methods - Google Patents

Treatment methods

Info

Publication number
GB0130763D0
GB0130763D0 GBGB0130763.6A GB0130763A GB0130763D0 GB 0130763 D0 GB0130763 D0 GB 0130763D0 GB 0130763 A GB0130763 A GB 0130763A GB 0130763 D0 GB0130763 D0 GB 0130763D0
Authority
GB
United Kingdom
Prior art keywords
treatment methods
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0130763.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NORGINE RES Ltd
Original Assignee
NORGINE RES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NORGINE RES Ltd filed Critical NORGINE RES Ltd
Priority to GBGB0130763.6A priority Critical patent/GB0130763D0/en
Publication of GB0130763D0 publication Critical patent/GB0130763D0/en
Priority to CNA028253248A priority patent/CN1604773A/zh
Priority to EP10177730A priority patent/EP2275099A1/en
Priority to US10/499,873 priority patent/US20050096397A1/en
Priority to AU2002353206A priority patent/AU2002353206B2/en
Priority to RU2004122639/15A priority patent/RU2332989C2/ru
Priority to MXPA04006142A priority patent/MXPA04006142A/es
Priority to CN2011104050612A priority patent/CN102516101A/zh
Priority to CNA2009101594203A priority patent/CN101601665A/zh
Priority to EP02788224A priority patent/EP1458370A1/en
Priority to CA2471046A priority patent/CA2471046C/en
Priority to PCT/GB2002/005864 priority patent/WO2003055474A1/en
Priority to PL369828A priority patent/PL217404B1/pl
Priority to JP2003556052A priority patent/JP5486143B2/ja
Priority to ZA2004/04813A priority patent/ZA200404813B/en
Priority to US12/586,973 priority patent/US8491931B2/en
Priority to JP2011041076A priority patent/JP2011105770A/ja
Priority to JP2011241937A priority patent/JP5544535B2/ja
Priority to US13/678,131 priority patent/US8613948B2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/08—Mydriatics or cycloplegics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/70—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0130763.6A 2001-12-21 2001-12-21 Treatment methods Ceased GB0130763D0 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
GBGB0130763.6A GB0130763D0 (en) 2001-12-21 2001-12-21 Treatment methods
JP2003556052A JP5486143B2 (ja) 2001-12-21 2002-12-20 １ｒ，２ｓ−メトキサミンを用いた便失禁および他の状態の処置
CNA2009101594203A CN101601665A (zh) 2001-12-21 2002-12-20 1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用
CA2471046A CA2471046C (en) 2001-12-21 2002-12-20 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
US10/499,873 US20050096397A1 (en) 2001-12-21 2002-12-20 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine
AU2002353206A AU2002353206B2 (en) 2001-12-21 2002-12-20 Treatment of faecal incontinence and other conditions with 1R, 2S-Methoxamine
RU2004122639/15A RU2332989C2 (ru) 2001-12-21 2002-12-20 Способ получения 1r,2s-метоксамина, его терапевтическое применение (варианты) и фармацевтическая композиция
MXPA04006142A MXPA04006142A (es) 2001-12-21 2002-12-20 Tratamiento de incontinencia fecal y otras condiciones con 1r, 2s-metoxamina.
CN2011104050612A CN102516101A (zh) 2001-12-21 2002-12-20 1r,2s-甲氧胺在制备治疗大便失禁和其他相关疾病的药物中的应用
CNA028253248A CN1604773A (zh) 2001-12-21 2002-12-20 用1r,2s－甲氧胺治疗大便失禁和其他相关疾病
EP02788224A EP1458370A1 (en) 2001-12-21 2002-12-20 Treatment of faecal incontinence and other conditions with 1r,2s-methoxamine
EP10177730A EP2275099A1 (en) 2001-12-21 2002-12-20 Treatment of faecal incontinence with 1r,2s-methoxamine
PCT/GB2002/005864 WO2003055474A1 (en) 2001-12-21 2002-12-20 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
PL369828A PL217404B1 (pl) 2001-12-21 2002-12-20 1R, 2S-Metoksamina i jej zastosowanie, kompozycja farmaceutyczna zawierająca 1R, 2S-Metoksaminę oraz sposób jej wytwarzania
ZA2004/04813A ZA200404813B (en) 2001-12-21 2004-06-17 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine
US12/586,973 US8491931B2 (en) 2001-12-21 2009-09-30 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine
JP2011041076A JP2011105770A (ja) 2001-12-21 2011-02-28 １ｒ，２ｓ−メトキサミンを用いた便失禁および他の状態の処置
JP2011241937A JP5544535B2 (ja) 2001-12-21 2011-11-04 １ｒ，２ｓ−メトキサミンを用いた便失禁および他の状態の処置
US13/678,131 US8613948B2 (en) 2001-12-21 2012-11-15 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130763.6A GB0130763D0 (en) 2001-12-21 2001-12-21 Treatment methods

Publications (1)

Publication Number Publication Date
GB0130763D0 true GB0130763D0 (en) 2002-02-06

Family

ID=9928258

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0130763.6A Ceased GB0130763D0 (en) 2001-12-21 2001-12-21 Treatment methods

Country Status (12)

Country Link
US (3) US20050096397A1 (enExample)
EP (2) EP1458370A1 (enExample)
JP (3) JP5486143B2 (enExample)
CN (3) CN101601665A (enExample)
AU (1) AU2002353206B2 (enExample)
CA (1) CA2471046C (enExample)
GB (1) GB0130763D0 (enExample)
MX (1) MXPA04006142A (enExample)
PL (1) PL217404B1 (enExample)
RU (1) RU2332989C2 (enExample)
WO (1) WO2003055474A1 (enExample)
ZA (1) ZA200404813B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130763D0 (en) * 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
GB0501580D0 (en) * 2005-01-25 2005-03-02 Norgine Europe Bv Compounds for treating urinary incontinence
EP2473056A4 (en) 2009-09-04 2013-02-13 Glaxosmithkline Llc CHEMICAL COMPOUNDS
ES2630102T3 (es) * 2011-04-26 2017-08-18 Rdd Pharma Ltd. Oximetazolina para el tratamiento de trastornos ano-rectales
CN102976961B (zh) * 2012-12-24 2014-09-24 武汉武药制药有限公司 盐酸甲氧明的制备方法
US10708086B2 (en) * 2016-01-19 2020-07-07 National Instruments Corporation Channel sounding techniques

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593261A (en) * 1976-07-23 1981-07-15 Inveresk Res Int Controlled release suppository
JPS60172953A (ja) * 1984-02-17 1985-09-06 Sagami Chem Res Center 光学活性β−アミノアルコ−ルの製造方法
FR2647014B1 (fr) * 1989-05-16 1991-08-30 Paris V Universite Composition medicamenteuse pour le traitement et la prevention des symptomes de l'insuffisance cardiaque, renfermant un agent alpha-stimulant vasoconstricteur comme principe actif
DK339289D0 (da) 1989-07-07 1989-07-07 Dak Lab As Farmaceutisk praeparat
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
NL9102142A (nl) * 1991-12-20 1993-07-16 Dagra Pharma Bv Zetpillen met vertraagde afgifte en werkwijze voor de bereiding daarvan.
US6635678B1 (en) * 1996-12-23 2003-10-21 S.L.A. Pharma Ag Pharmaceutical composition for treating fecal incontinence
WO1998038587A1 (en) * 1997-02-26 1998-09-03 Siebel Systems, Inc. Method of using a cache to determine the visibility to a remote database client of a plurality of database transactions
US6539381B1 (en) * 1999-04-21 2003-03-25 Novell, Inc. System and method for synchronizing database information
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
US6544927B2 (en) * 2001-04-28 2003-04-08 University Of Florida Use of α2-adrenergic receptor agonists and adrenergic inhibitors in reducing defoliation
GB0130763D0 (en) 2001-12-21 2002-02-06 Norgine Res Ltd Treatment methods
US7089228B2 (en) * 2002-04-18 2006-08-08 International Business Machines Corporation Computer apparatus and method for caching results of a database query

Also Published As

Publication number Publication date
WO2003055474A1 (en) 2003-07-10
US20100022657A1 (en) 2010-01-28
MXPA04006142A (es) 2005-03-31
PL369828A1 (en) 2005-05-02
US20050096397A1 (en) 2005-05-05
PL217404B1 (pl) 2014-07-31
JP2005519888A (ja) 2005-07-07
CA2471046A1 (en) 2003-07-10
US8613948B2 (en) 2013-12-24
JP5544535B2 (ja) 2014-07-09
JP2012025782A (ja) 2012-02-09
CN101601665A (zh) 2009-12-16
ZA200404813B (en) 2005-10-26
EP2275099A1 (en) 2011-01-19
JP2011105770A (ja) 2011-06-02
AU2002353206B2 (en) 2008-09-04
RU2332989C2 (ru) 2008-09-10
CA2471046C (en) 2012-02-07
RU2004122639A (ru) 2005-05-10
CN1604773A (zh) 2005-04-06
AU2002353206A1 (en) 2003-07-15
CN102516101A (zh) 2012-06-27
EP1458370A1 (en) 2004-09-22
US20130072567A1 (en) 2013-03-21
JP5486143B2 (ja) 2014-05-07
US8491931B2 (en) 2013-07-23

Similar Documents

Publication Publication Date Title
GB0112343D0 (en) Well treatment
EP1463438A4 (en) ENDOMURAL THERAPY
GB0028264D0 (en) Well treatment
GB0113751D0 (en) Surface treatment
GB0028269D0 (en) Well treatment
GB0129976D0 (en) Treatment method
GB0108968D0 (en) Methods
GB0118383D0 (en) Therapeutic methods
EP1422743A4 (en) TREATMENT SYSTEM
GB0120042D0 (en) Methods
GB0126251D0 (en) Methods
GB0120147D0 (en) Treatment method
GB0124124D0 (en) Methods of treatment
GB0111146D0 (en) Methods
GB0101933D0 (en) Therapy
GB0116249D0 (en) Methods
GB0127384D0 (en) Well treatment system
GB0130763D0 (en) Treatment methods
GB0103031D0 (en) Novel treatment
GB0118549D0 (en) Methods
GB0126253D0 (en) Treatment method
GB0130694D0 (en) Treatment
GB0118611D0 (en) Methods
GB0116837D0 (en) Treatment
GB0109519D0 (en) Nimico treatment

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)